Trial
NCT04915846
Tamoxifen Therapy for Myotubular Myopathy
Phase ITERMINATEDSAFETYConfidence: HIGH
Sponsor
James Dowling
Collaborators
Canadian Institutes of Health Research (CIHR); Cures Within Reach; The Joshua Frase Foundation USA; Will Cure USA; Mogford Campbell Family Chair Fund; Myotubular Trust; Great Ormond Street Hospital Charity; Sparks
Condition
X Linked Myotubular Myopathy
Intervention
ApoTamox 10mg
Why stopped
Study terminated due to safety concerns.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-09-19